AstraZeneca’s US listing plan backed by key shareholder advisers
- Posted on October 14, 2025
- By The Times
- 3 Views
AstraZeneca’s US listing plan backed by key shareholder advisers
Glass Lewis and Pirc has recommended that investors support the pharma giant’s proposals, which are seen as a pivot towards America
